학술논문

Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
Document Type
Article
Source
Frontiers in Oncology; 3/22/2022, Vol. 12, p1-16, 16p
Subject
RECTAL cancer
NEOADJUVANT chemotherapy
FISHER discriminant analysis
COMBINED modality therapy
BACTERIAL diversity
RIBOSOMAL RNA
Language
ISSN
2234943X
Abstract
Copyright of Frontiers in Oncology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)